器官晶片市场－全球产业规模、份额、趋势、机会和预测，按类型、按产品、按材料类型、按应用、按最终用户、按地区和竞争进行细分，2020 年至 2030 年预测

2024年，全球器官晶片市场规模达4.6757亿美元，预计在预测期内将显着成长，到2030年复合年增长率将达到25.61%。器官晶片是人体器官的精密人工复製品。这些尖端设备利用多通道3D微流控细胞培养技术，忠实模拟器官的功能、过程和生理反应。透过将晶片实验室（LOC）与细胞生物学结合，研究人员成功创建了一种新型的体外多细胞人体模型，从而能够在器官特定环境下分析人体生理学。

市场概览
预测期	2026-2030
2024年市场规模	4.6757亿美元
2030年市场规模	18.04亿美元
2025-2030 年复合年增长率	25.61%
成长最快的领域	製药和生物技术公司
最大的市场	北美洲

这些晶片具有设计精巧的微通道，可促进血液和气流流动，从而能够模拟各种器官，例如肺、肠、脑、肝和心臟。微晶片中植入活细胞，透过持续灌注促进组织和器官功能。器官晶片技术以其独特的硅营养、组织工程和微流体技术相结合，有望彻底改变该领域。这些进步在解决药物研发和疾病治疗领域长期存在的挑战方面拥有巨大的潜力，使其成为药物研发研究的关键组成部分，并推动器官晶片产业的发展。

关键市场驱动因素

电子晶片小型化需求日益增长

主要市场挑战

器官晶片设备成本高引发担忧

主要市场趋势

市场发展日益

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球器官晶片市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（肝臟、心臟、肺、肾、其他）
  • 按产品（产品与服务）
  • 依材料类型（聚合物、PDMS、玻璃、硅、其他）
  • 按应用（生理模型开发、药物发现、毒理学研究、分子生物学、其他）
  • 按最终用户（製药和生物技术公司、学术和研究机构、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美器官晶片市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲器官晶片市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太器官晶片市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美器官晶片市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲器官晶片市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球器官晶片市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Altis Biosystems
• AxoSim Inc.
• BiomimX SRL
• Emulate Inc.
• Hesperos
• Allevi Inc.
• InSphero AG
• MIMETAS BV
• Nortis Inc.
• Hesperos, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Organ-on-Chip Market was valued at USD 467.57 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 25.61% through 2030. Organs-on-chip are sophisticated artificial replicas of human organs. These cutting-edge devices utilize multichannel 3D microfluidic cell culture technology to faithfully mimic organ functions, processes, and physiological responses. By combining labs-on-chips (LOCs) with cell biology, researchers have successfully created a novel model of in vitro multicellular human beings, allowing for the analysis of human physiology within organ-specific environments.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 467.57 Million
Market Size 2030	USD 1804.00 Million
CAGR 2025-2030	25.61%
Fastest Growing Segment	Pharmaceutical & Biotechnology Companies
Largest Market	North America

These chips feature intricately designed microchannels that facilitate blood and air flow, enabling the simulation of various organs such as the lung, intestine, brain, liver, and heart. The microchips are populated with live cells, fostering tissue and organ function through constant perfusion. Organ-on-chip technology, with its unique blend of silicone nourishment, tissue engineering, and microfluidics, has the potential to revolutionize the field. These advancements hold great promise in addressing longstanding challenges in drug discovery and disease treatment, making it a crucial component in drug development investigations and propelling the organ-on-chip industry forward.

Key Market Drivers

Growing Demand of Miniaturization of Electronic Chips

The growing prevalence for microchips in the field of medical devices is a direct result of remarkable technological advancements. These advancements have not only fueled the demand for such devices but also paved the way for significant improvements in their construction and maintenance. The process of miniaturization has played a key role in achieving these advancements, as it allows for the reduction of materials required to build and sustain the system.

Moreover, the utilization of microfluidic chips has revolutionized the development of miniaturized tissues, enabling the simulation of real tissue in organ-on-a-chip systems. By creating an in vitro environment at the microscopic scale, these microfluidic chips effectively mimic the function and structure of actual organs. This breakthrough technology holds tremendous promise in advancing our understanding of organ function and disease progression. The integration of microchips and microfluidic chips in medical devices marks a significant milestone in the field of healthcare. With continued research and innovation, we can expect even greater advancements in this fascinating area, ultimately leading to improved diagnostics, treatments, and overall patient care.

Key Market Challenges

Concerns Pertaining due to High Cost of Organ Chip Device

The high cost associated with the organ chip device, coupled with the fact that organ-on-chip (OOC) technology is still in its early stages, is projected to limit the expansion of the market. This is primarily due to the significant investment required for research and development, manufacturing, and commercialization of organ-on-chip devices. The complex nature of the technology, involving the integration of multiple organ models and microfluidic systems, adds to the manufacturing challenges and cost considerations.

Furthermore, certain countries have imposed restrictions on cosmetic testing on animals, which is likely to further hinder the growth of the global organ-on-chip market. In these countries, the government has prohibited the use of animals for testing cosmetics developed within their borders, reflecting a growing awareness and concern for animal welfare. This shift in regulatory policies has prompted the need for alternative testing methods, such as organ-on-chip technology, which can simulate the physiological conditions of human organs and provide more accurate and ethical results.

These factors collectively contribute to the complex landscape surrounding the adoption and market potential of organ-on-chip technology. While the technology holds great promise for revolutionizing drug discovery, toxicity testing, and personalized medicine, overcoming the barriers of cost, scale-up, and regulatory requirements remains crucial for its widespread adoption and market success. Continued advancements in technology, coupled with collaborative efforts between academia, industry, and regulatory bodies, will play a vital role in addressing these challenges and unlocking the full potential of organ-on-chip technology in improving healthcare outcomes.

Key Market Trends

Increasing Market Developments

The organ-on-chip market is witnessing significant growth largely driven by a series of strategic market developments such as product launches, collaborations, mergers, and acquisitions. Companies in this space are continuously innovating by launching new organ-on-chip devices that more accurately mimic human organs and their functions. These innovations not only improve the reliability and efficiency of the technology but also expand its applications across various fields including drug discovery, toxicology testing, and personalized medicine. As new products emerge, they attract a broader range of customers, which helps drive the overall market expansion.

Collaborations between biotech firms, pharmaceutical companies, and research institutions are playing a crucial role in accelerating the development and commercialization of organ-on-chip technologies. By combining expertise and resources, these partnerships help in speeding up research, validating new models, and entering new markets. Additionally, collaborations often enable sharing of high-cost resources and access to advanced technology platforms, which further promotes innovation and market penetration.

Mergers and acquisitions are also key drivers of growth in the organ-on-chip market. Larger companies are acquiring smaller startups that have developed innovative technologies, allowing them to quickly integrate new capabilities and expand their product portfolios. These consolidations provide companies with enhanced financial and technical resources, enabling more substantial investments in research and marketing. Moreover, such activities help strengthen competitive positioning and broaden the reach of organ-on-chip solutions.

Another important factor fueling market growth is increased funding from venture capital, government grants, and other investors. This influx of capital supports further innovation, clinical validation, and regulatory approval processes, all of which are critical to bringing advanced organ-on-chip products to market. In parallel, regulatory agencies are gradually recognizing the value of organ-on-chip platforms as alternatives to traditional animal testing, which has encouraged adoption by reducing barriers related to compliance and ethical concerns.

Key Market Players

• Altis Biosystems
• AxoSim Inc.
• BiomimX SRL
• Emulate Inc.
• Hesperos
• Allevi Inc.
• InSphero AG
• MIMETAS BV
• Nortis Inc.
• Hesperos, Inc.

Report Scope:

In this report, the Global Organ-on-Chip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ-on-Chip Market, By Type:

• Liver
• Heart
• Lung
• Kidney
• Others

Organ-on-Chip Market, By Offering:

• Products
• Services

Organ-on-Chip Market, By Material Type:

• Polymer
• PDMS
• Glass
• Silicon
• Others

Organ-on-Chip Market, By Application:

• Physiological Model Development
• Drug Discovery
• Toxicological Research
• Molecular Biology
• Others

Organ-on-Chip Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

Organ-on-Chip Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ-on-Chip Market.

Available Customizations:

Global Organ-on-Chip market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ-on-Chip Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Liver, Heart, Lung, Kidney, Others)
  • 5.2.2. By Offering (Products v/s Services)
  • 5.2.3. By Material Type (Polymer, PDMS, Glass, Silicon, Others)
  • 5.2.4. By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others)
  • 5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Organ-on-Chip Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Offering
  • 6.2.3. By Material Type
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organ-on-Chip Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Offering
      • 6.3.1.2.3. By Material Type
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Organ-on-Chip Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Offering
      • 6.3.2.2.3. By Material Type
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Organ-on-Chip Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Offering
      • 6.3.3.2.3. By Material Type
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Organ-on-Chip Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Offering
  • 7.2.3. By Material Type
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organ-on-Chip Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Offering
      • 7.3.1.2.3. By Material Type
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Organ-on-Chip Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Offering
      • 7.3.2.2.3. By Material Type
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Organ-on-Chip Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Offering
      • 7.3.3.2.3. By Material Type
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Organ-on-Chip Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Offering
      • 7.3.4.2.3. By Material Type
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Organ-on-Chip Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Offering
      • 7.3.5.2.3. By Material Type
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Organ-on-Chip Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Offering
  • 8.2.3. By Material Type
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Organ-on-Chip Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Offering
      • 8.3.1.2.3. By Material Type
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Organ-on-Chip Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Offering
      • 8.3.2.2.3. By Material Type
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Organ-on-Chip Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Offering
      • 8.3.3.2.3. By Material Type
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Organ-on-Chip Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Offering
      • 8.3.4.2.3. By Material Type
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Organ-on-Chip Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Offering
      • 8.3.5.2.3. By Material Type
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Organ-on-Chip Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Offering
  • 9.2.3. By Material Type
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Organ-on-Chip Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Offering
      • 9.3.1.2.3. By Material Type
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Organ-on-Chip Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Offering
      • 9.3.2.2.3. By Material Type
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Organ-on-Chip Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Offering
      • 9.3.3.2.3. By Material Type
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Organ-on-Chip Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Offering
  • 10.2.3. By Material Type
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Organ-on-Chip Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Offering
      • 10.3.1.2.3. By Material Type
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Organ-on-Chip Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Offering
      • 10.3.2.2.3. By Material Type
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Organ-on-Chip Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Offering
      • 10.3.3.2.3. By Material Type
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Organ-on-Chip Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Altis Biosystems
  • 15.1.1. Business Overview
  • 15.1.2. Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. AxoSim Inc.
• 15.3. BiomimX SRL
• 15.4. Emulate Inc.
• 15.5. Hesperos
• 15.6. Allevi Inc.
• 15.7. InSphero AG
• 15.8. MIMETAS BV
• 15.9. Nortis Inc.
• 15.10. Hesperos, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer